What if monoclonal antibodies could pave the way for the cure of allergic pathologies?
Many researchers are indeed interested in the use of these biotherapies as a gateway to immunotherapy (or desensitization) for patients who currently do not have access to them.
Immunotherapy consists in exposing an allergic patient to increasing doses of the allergen(s) to which he is sensitive.
The body thus becomes accustomed to its presence and no longer triggers an uncontrolled emergency reaction - and potentially dangerous - in the face of this intruder wrongly perceived as a major threat.
This approach has been used for more than a century by many allergists, more or less empirically with more or less notable successes and failures.
Scientific work has nevertheless made it possible to establish precise protocols for a certain number of allergens, in particular responsible for respiratory allergies, in order to optimize the method.
The…
This article is for subscribers only.
You have 67% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login